Brief: Medadvisor Reaffirms FY22 Forecast
24/02/2022 23:58
Feb 25 (Reuters) - Medadvisor Ltd MDR.AX :
* REAFFIRMS ITS PREVIOUS GUIDANCE FOR FY22
Source text for Eikon: ID:nASX59Xtbj
Further company coverage: MDR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adheris Health
See all newsBrief: Adheris Health Posts Q3 Operating Revenue Of A$5.4M
Brief: Adheris Health Posts HY Profit From Ordinary Activities After Tax Attributable A$7.3 Million
Brief: Adheris Health Expects 30% Total Operating Cost Savings Over Two Years
Brief: Adheris Health Posts Q2 Operating Revenue A$13.7 Million
Brief: Adheris Health Says A$6.1M Holdback Consideration Received